It was used to eliminate a metastasis in 11.8% of cases, discarding lung adenocarcinoma or thyroid carcinoma (TTF1-), epidermoid carcinoma (p63-), and melanoma (pS100, MelanA, HMB45). Here, PMEL is linked to melanoma.